JP2011121949A5 - - Google Patents

Download PDF

Info

Publication number
JP2011121949A5
JP2011121949A5 JP2010278550A JP2010278550A JP2011121949A5 JP 2011121949 A5 JP2011121949 A5 JP 2011121949A5 JP 2010278550 A JP2010278550 A JP 2010278550A JP 2010278550 A JP2010278550 A JP 2010278550A JP 2011121949 A5 JP2011121949 A5 JP 2011121949A5
Authority
JP
Japan
Prior art keywords
sod1
ips cell
cell
test compound
ips
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2010278550A
Other languages
English (en)
Japanese (ja)
Other versions
JP2011121949A (ja
Filing date
Publication date
Application filed filed Critical
Publication of JP2011121949A publication Critical patent/JP2011121949A/ja
Publication of JP2011121949A5 publication Critical patent/JP2011121949A5/ja
Pending legal-status Critical Current

Links

JP2010278550A 2009-12-14 2010-12-14 筋萎縮性側索硬化症の予防および治療用医薬組成物 Pending JP2011121949A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US28613409P 2009-12-14 2009-12-14
US61/286,134 2009-12-14

Publications (2)

Publication Number Publication Date
JP2011121949A JP2011121949A (ja) 2011-06-23
JP2011121949A5 true JP2011121949A5 (enExample) 2014-02-06

Family

ID=44167440

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2010278550A Pending JP2011121949A (ja) 2009-12-14 2010-12-14 筋萎縮性側索硬化症の予防および治療用医薬組成物

Country Status (4)

Country Link
US (1) US20130115622A1 (enExample)
EP (1) EP2512514B1 (enExample)
JP (1) JP2011121949A (enExample)
WO (1) WO2011074690A1 (enExample)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2012067265A1 (en) * 2010-11-18 2012-05-24 Kyoto University Method for screening drugs for suppressing inflammasome activity
WO2013140927A1 (ja) * 2012-03-21 2013-09-26 国立大学法人京都大学 アルツハイマー病の治療薬および/または予防薬のスクリーニング方法
WO2014020933A1 (ja) * 2012-07-31 2014-02-06 アルバイオ株式会社 新規蛍光物質
EP2938721B1 (en) * 2012-12-28 2019-10-16 Kyoto University Method for inducing astrocytes
SG11201507829SA (en) 2013-03-21 2015-12-30 Univ Kyoto Pluripotent stem cell for neuronal differentiation induction
JP6856266B2 (ja) * 2013-12-02 2021-04-07 国立大学法人京都大学 Ｆｇｆｒ３病の予防および治療剤ならびにそのスクリーニング方法
EP3246046A4 (en) 2015-01-13 2018-12-05 Kyoto University Agent for preventing and/or treating amyotrophic lateral sclerosis
US10842822B2 (en) 2015-10-05 2020-11-24 Orig3N, Inc. Diagnosis and treatment of parkinson's disease based on identification and amelioration of liver dysfunction
CN108624560B (zh) * 2018-06-01 2022-04-08 南京艾尔普再生医学科技有限公司 一种分化培养基及少突胶质前体细胞的制备方法
US12533383B2 (en) 2019-09-06 2026-01-27 Keio University Method for producing cell aggregate including glial progenitor cells
CN113842449B (zh) * 2021-09-08 2024-02-23 乐卫东 枸杞糖肽在制备预防和/或治疗肌萎缩侧索硬化的药物中的应用

Family Cites Families (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4231938A (en) 1979-06-15 1980-11-04 Merck & Co., Inc. Hypocholesteremic fermentation products and process of preparation
ZA81703B (en) 1980-02-04 1982-09-29 Merck & Co Inc New antihypercholesterolemic compounds,intermediates and processes
US4444784A (en) 1980-08-05 1984-04-24 Merck & Co., Inc. Antihypercholesterolemic compounds
MX7065E (es) 1980-06-06 1987-04-10 Sankyo Co Un procedimiento microbiologico para preparar derivados de ml-236b
JPS572240A (en) 1980-06-06 1982-01-07 Sankyo Co Ltd Ml-236b derivative
US4739073A (en) 1983-11-04 1988-04-19 Sandoz Pharmaceuticals Corp. Intermediates in the synthesis of indole analogs of mevalonolactone and derivatives thereof
JPS60500015A (ja) 1982-11-22 1985-01-10 サンド・アクチエンゲゼルシヤフト メバロラクトン同族体とその誘導体、これらの製造法およびこれらを含有する製薬学的組成物
JP2569746B2 (ja) 1987-08-20 1997-01-08 日産化学工業株式会社 キノリン系メバロノラクトン類
US5854259A (en) 1987-08-20 1998-12-29 Nissan Chemical Industries Ltd. Quinoline type mevalonolactones
FI94339C (fi) 1989-07-21 1995-08-25 Warner Lambert Co Menetelmä farmaseuttisesti käyttökelpoisen /R-(R*,R*)/-2-(4-fluorifenyyli)- , -dihydroksi-5-(1-metyylietyyli)-3-fenyyli-4-/(fenyyliamino)karbonyyli/-1H-pyrroli-1-heptaanihapon ja sen farmaseuttisesti hyväksyttävien suolojen valmistamiseksi
JP2648897B2 (ja) 1991-07-01 1997-09-03 塩野義製薬株式会社 ピリミジン誘導体
FR2688138B1 (fr) 1992-03-06 1995-05-05 Rhone Poulenc Rorer Sa Application de l'amino-2 trifluoromethoxy-6 benzothiazole pour obtenir un medicament destine au traitement de la sclerose laterale amyotrophique.
US7011828B2 (en) 2000-03-14 2006-03-14 Es Cell International Pte. Ltd. Implanting neural progenitor cells derived for human embryonic stem cells
JP4458222B2 (ja) 2000-05-16 2010-04-28 独立行政法人理化学研究所 胚性幹細胞の外胚葉系細胞への新規な分化誘導法及びその用途
JP4294482B2 (ja) 2001-11-15 2009-07-15 協和発酵キリン株式会社 胚性幹細胞から外胚葉系細胞への分化誘導剤、その取得方法及びその用途
WO2004000313A2 (fr) * 2002-06-24 2003-12-31 Exonhit Therapeutics Sa Traitement de la sclerose laterale amyotrophique avec des composes modulateurs de l’activite de pgc-1
US20050202488A1 (en) * 2004-03-02 2005-09-15 The General Hospital Corporation Assay for therapies that inhibit expression of the cytosolic Cu/Zn superoxide dismutase (SOD1) gene
JP5141016B2 (ja) 2004-06-18 2013-02-13 独立行政法人理化学研究所 無血清浮遊培養による胚性幹細胞の神経分化誘導法
WO2006105806A1 (en) * 2005-04-07 2006-10-12 Miso Sabovic Delaying the ageing process and disorders caused by ageing
US20060252775A1 (en) * 2005-05-03 2006-11-09 Henderson Samuel T Methods for reducing levels of disease associated proteins
EP2206724A1 (en) 2005-12-13 2010-07-14 Kyoto University Nuclear reprogramming factor
EP2514824A3 (en) * 2006-03-03 2013-01-23 Amorfix Life Sciences Ltd. Methods and compositions to treat and detect misfolded-SOD1 mediated diseases
DK3399025T3 (da) 2007-03-23 2025-06-16 Wisconsin Alumni Res Found Omprogrammering af somatiske celler
WO2008127974A1 (en) * 2007-04-13 2008-10-23 The Trustees Of Columbia University In The City Of New York Stem cell-based culture system for drug development
JP2009215191A (ja) * 2008-03-07 2009-09-24 Keio Gijuku 神経損傷治療剤及び神経損傷治療方法
WO2009146098A2 (en) * 2008-04-02 2009-12-03 President And Fellows Of Harvard College Stem cells and uses thereof

Similar Documents

Publication Publication Date Title
Cheng et al. Adsorption behavior of direct red 80 and congo red onto activated carbon/surfactant: Process optimization, kinetics and equilibrium
WO2012092364A3 (en) Method for sympathetic rebalancing of patient
JP2012518389A5 (enExample)
Goffaux et al. Improving continuous–discrete interval observers with application to microalgae-based bioprocesses
WO2013052915A3 (en) Method for detecting replication or colonization of a biological therapeutic
JP2011525793A5 (enExample)
JP2011080061A5 (enExample)
CA2812940A1 (en) Compositions and methods useful for the treatment and diagnosis of inflammatory bowel disease
WO2008079469A3 (en) Genetically engineered biological indicator
BR112014010445A2 (pt) métodos e aparelho para reprodução neural não supervisionada, refinamento de aprendizagem, associação e transferência de memória: aprendizagem associativa neural, conclusão, separação, generalização e reprodução hierárquica de padrão
GB2514970A (en) Enhanced storage of metadata utilizing improved error detection and correction in computer memory
WO2011085075A3 (en) Assembly of high fidelity polynucleotides
JP2014208682A5 (enExample)
EP2838842A4 (en) METHOD AND REACTORS FOR PRODUCING SOLID CARBON NANOTONES, SOLID CARBON CLUSTERS AND WOODS
EP2888369A4 (en) MICRO-ORGANISMS AND METHODS FOR IMPROVING THE AVAILABILITY OF REDUCING EQUIVALENTS IN THE PRESENCE OF METHANOL AND FOR THE PREPARATION OF 1,4-BANDALIUM
JP2011525899A5 (enExample)
JP2015512868A5 (ja) ビニルエステル及び酢酸又はプロピオン酸反応生成物の共製造の第一段階としてのトランスビニル化
FR2969762B1 (fr) Sonde de microscope a force atomique, son procede de preparation et ses utilisations
JP2016063801A5 (enExample)
JP2011530484A5 (enExample)
JP2010166901A5 (enExample)
WO2015064718A8 (ja) 光架橋形成抑制方法、及び自己架橋体形成抑制型光応答性核酸
JP2009523791A5 (enExample)
WO2015040497A3 (en) Methods for nuclear reprogramming of cells
BR112016028185A2 (pt) método para produzir um l-aminoácido.